Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

Immunology

Volumn 93, Issue 1, 1998, Pages 1-10

  Ryan, M ^a   Murphy, G ^a   Ryan, E ^a   Nilsson, L ^b   Shackley, F ^c   Gothefors, L ^d   Oymar K ^e   Miller, E ^f   Storsaeter, J ^g,h   Mills, K H G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UMEÅ UNIVERSITY   (Sweden)

^e Department of Pediatrics   (Norway)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g SACHS CHILDREN S HOSPITAL   (Sweden)

^h Box 4092   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ANTIGEN PURIFICATION; ARTICLE; BORDETELLA PERTUSSIS; CELL KILLING; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LUNG ALVEOLUS MACROPHAGE; PERTUSSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; CELL CULTURE TECHNIQUES; CHILD; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; PERTUSSIS VACCINE; T-LYMPHOCYTE SUBSETS; VACCINATION;

EID: 15444357278     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00401.x     Document Type: Article

References (31)

1. CHERRY J.D., BRUNNELL P.A., GODEN G.S. & KARZON D.T. (1988) Report of the task force on pertussis and pertussis immunization - 1988. Pediatrics 81 (suppl), 939.
2. Report from the PHLS epidemiological research laboratory & 21 area health authorities (1982) Efficacy of pertussis vaccination in England. Br Med J 285, 357.
3. HEININGER U., CHERRY J.D., CHRISTENSON PD et al. (1994) Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine 12, 81.
4. TROLLFORS B., TARANGER J., LAGERGÅRD T. et al. (1995) A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 333, 1045.
5. GRECO D., SALMASO S., MASTRANTONIO P. et al. (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 334, 341.
6. GUSTAFSSON L., HALLANDER H.O., OLIN P., REIZENSTEIN E. & STORSAETER J. (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334, 349.
7. SIMONDON F, PREZIOSI, M.-P YAM, A. et al. (1997) Randomized double blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 15, 1606.
8. EDWARDS K.E., MEADE B.D., DECKER M.D. et al. (1995) Comparison of 13 acellular pertussis vaccines: overview and serological response. Pediatrics 96, 548.
9. MILLER E., ASHWORTH L.A.E., REDHEAD K., THORNTON C., WAIGHT P.A. & COLEMAN T. (1997) Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell vaccines: value of laboratory tests as predictors of clinical performance. Vaccine 15, 51.
10. STORSAETER J. & GUSTAFSON L. (1996) Swedish household study, estimates of vaccine efficacy and preliminary indications of serological correlates between antibody levels and in pre-exposure sera and protection against pertussis among household exposed children. In: National Institutes of Health Pertussis Conference. Acellular Pertussis Vaccine trials: Results and Impact on US Public Health, Washington DC, 1996 (abstract). National Institute of Allergy and Infectious Diseases, National Institute of Health, WA.
11. Ad hoc Group for the Study of Pertussis Vaccines (1988) Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events. Lancet i, 955.
12. MILLS K.H.G. & REDHEAD K. (1993) Cellular immunity in pertussis (Editorial). J Med Microbiol 39, 163.
13. MILLS K.H.G, BARNARD A., WATKINS J. & REDHEAD K. (1993) Cell-mediated immunity to Bordetella pertussis: role of T cells in bacterial clearance in a murine respiratory infection model. Infect Immun 61, 399.
14. REDHEAD K., WATKINS J., BARNARD A. & MILLS K.H.G. (1993) Effective immunization against Bordetella pertussis infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 61, 3190.
15. SAUKKONEN K., CEBELLOS C., BURROUGHS M., PRASAD S. & TUOMANEN E. (1991) Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med 173, 1143.
16. BROMBERG K., TANNIS G. & STEINER P. (1991) Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect Immun 59, 4715.
17. BARNARD A., MAHON B.P., WATKINS J., REDHEAD K. & MILLS K.H.G. (1996) Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T cell subsets as Th1, Th2 or Th0. Immunol 87, 372.
18. PETERSON J.W., ANDERSON P., IBSEN P.H. et al. (1993) Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine 11, 463.
19. RYAN M., MURPHY G., GOTHEFORS L., NILSSON L., STORSAETER J. & MILLS K.H.G. (1997) Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 Th cells J Infect Dis 175, 1246.
20. WIERTZ E.J.H.J., LOGGEN H.G., WALVOORT H.C. & KREEFTENBERG JG. (1989) In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans. J Biol Standards 17, 181.
21. PODDA A., NENCIONI L., DE MAGISTRIS M.T. et al. (1990) Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med 172, 861.
22. PETERSEN J.W., IBSEN P.H., BENTZON M.W., CAPIAU C. & HERON I. (1991) The cell-mediated and humoral immune response to vaccination with acellular and whole-cell pertussis vaccine in adult humans. FEMS Microbiol Immunol 3, 279.
23. CASSONE A., AUSIELLO C.M., URBANI F., LANDE R., GIULIANO S., FOR THE PROGETTO PERIOSSE-CMI WORKING GROUP (1997) Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines Arch Pediatr Adolesc Med 151, 283.
24. + T-cell clones against Bordetella pertussis. Infect Immun 59, 3768.
25. RYAN M., GOTHEFORS L., STORSAETER J. & MILLS K.H.G. (1997) B pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev Biol Standards 89, 251.
26. ZEPP F., KNUF M., HABERMEHL, P. et al. (1996) Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 64, 4078.
27. ABBAS A.K., MURPHY K.M. & SHER A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787.
28. ISACSON J., TROLLFORS B., TARANGER J. & LAGERGÅRD T. (1995) Acquisition of IgG serum antibodies against two Bordetella pertussis antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 14, 517.
29. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med 181, 1285.
30. MAHON B.P., RYAN M., GRIFFIN F. & MILLS K.H.G. (1996) Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting the induction of Th1 cells. Infect Immun. 64, 5295.
31. RYAN M. & MILLS K.H.G. (1997) The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells. Biochem Soc Trans 25 (suppl 1), 126.